tiprankstipranks

George Magrath Insider Profile

4 Followers
George Magrath, CEO at Ocuphire Pharma, holds 425.00K shares in Ocuphire Pharma (Ticker: OCUP). Most recently, George Magrath Bought $25,000 shares of Ocuphire Pharma on Mar 20, 2024 for an estimated value of 49.00K.
tipranks
George Magrath

George Magrath
Ocuphire Pharma (OCUP)
CEO

Not Ranked
George Magrath has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$674K
100.00%
A breakdown of George Magrath's holdings

Insider Roles

Ocuphire Pharma
(OCUP)
CEO
Roles that George Magrath holds in companies

Most Profitable Insider Trade

Stock:
Ocuphire Pharma
(OCUP)
Rating:Informative Buy
Date:Mar 20, 2024 - Today
Return:-18.60%
The most profitable trade made by George Magrath

George Magrath's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ocuphire Pharma
Mar 20, 2024
CEO
Informative Buy
49.00K
$673.63K
Success Rate for
OCUP
0 out of 1 profitable transactions on
OCUP
0%
Average Return for
OCUP
Average return per transaction on
OCUP
-18.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 03, 2023
Uninformative Buy
$0.00
-
$0.00
Mar 20, 2024
Informative Buy
$49.00K
-
$1.96
-18.60%
List of latest transactions for each holding click on a transaction to see George Magrath's performance on stock

George Magrath insider profile FAQ

What is the percentage of profitable transactions made by George Magrath?
The percentage of profitable transactions made by George Magrath is ―.
    What is the average return per transaction made by George Magrath?
    The average return per transaction made by George Magrath is ―.
      What stocks does George Magrath hold?
      George Magrath holds: OCUP stocks.
        What was George Magrath’s latest transaction?
        George Magrath latest transaction was an Informative Buy of $49.00K.
          What was George Magrath's most profitable transaction?
          George Magrath’s most profitable transaction was an Informative Buy of OCUP stock on March 20, 2024. The return on the trade was -18.60%.
            What is George Magrath's role in Ocuphire Pharma?
            George Magrath's role in Ocuphire Pharma is CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.